A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections
Authors 0
- Author list not loaded yet.
Cited by 2 stored of 59
2 results